Infection Prevention and Control Challenges and Adverse Event Prevention in Pakistani Healthcare Settings: A Narrative Review

Abstract

Background: Preventable adverse events remain a major patient-safety concern in Pakistani healthcare settings, where medication errors, surgical complications, surgical site infections, healthcare-associated infections, antimicrobial misuse, and underreporting of adverse events are shaped by both clinical and system-level weaknesses. Existing evidence is dispersed across clinical, public-health, and health-system literature, limiting integrated understanding of how infection prevention and control challenges interact with broader organizational and governance barriers. Objective: This narrative mini-review aimed to synthesize available evidence on infection prevention and control challenges and adverse event prevention in Pakistani healthcare settings, with emphasis on clinical safety problems, systemic determinants, and feasible prevention strategies. Methods: A structured narrative search was conducted using PubMed, Scopus, Web of Science, CINAHL, and Google Scholar for English-language literature published from 2005 to 2024. Search concepts included adverse events, patient safety, medication errors, surgical complications, surgical site infections, healthcare-associated infections, infection prevention and control, antimicrobial stewardship, healthcare quality, root-cause analysis, and Pakistan. Eligible sources included original research, review articles, case studies, policy-relevant reports, and grey literature addressing adverse-event occurrence, determinants, or prevention in Pakistani healthcare settings. Evidence was synthesized thematically because of heterogeneity in study designs, populations, outcomes, and reporting methods. Results: The synthesis identified medication errors, surgical complications and surgical site infections, healthcare-associated infections, antimicrobial misuse, and underreporting of adverse events as major patient-safety domains. Key contributing factors included illegible or incomplete prescriptions, limited pharmacist involvement, inconsistent surgical checklist use, weak IPC infrastructure, antibiotic misuse, inadequate surveillance, workplace violence, punitive reporting culture, ethical and governance gaps, professional hierarchy, and socio-cultural delays in care-seeking. Priority prevention strategies included standardized prescribing, phased electronic health records, pharmacist-led medication review, WHO Surgical Safety Checklist implementation, IPC care bundles, antimicrobial stewardship, non-punitive incident reporting, workforce protection, and multidisciplinary safety teams. Conclusion: Adverse event prevention in Pakistan requires integrated action across clinical practice, hospital administration, and health policy. Sustainable improvement depends on combining practical bedside interventions with stronger IPC capacity, reporting culture, workforce safety, multidisciplinary collaboration, surveillance, and transparent governance.